{"id":"https://openalex.org/W2808935978","doi":"https://doi.org/10.2337/db18-1207-p","title":"Rapid Dose Escalation Study of Praliciguat, a Soluble Guanylate Cyclase Stimulator, in Patients with Diabetes and Hypertension","display_name":"Rapid Dose Escalation Study of Praliciguat, a Soluble Guanylate Cyclase Stimulator, in Patients with Diabetes and Hypertension","publication_year":2018,"publication_date":"2018-06-22","ids":{"openalex":"https://openalex.org/W2808935978","doi":"https://doi.org/10.2337/db18-1207-p","mag":"2808935978"},"language":"en","primary_location":{"id":"doi:10.2337/db18-1207-p","doi":"https://doi.org/10.2337/db18-1207-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-1207-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045134254","display_name":"John P. Hanrahan","orcid":"https://orcid.org/0000-0002-7095-9490","observed_orcids":["https://orcid.org/0000-0002-7095-9490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JOHN P. HANRAHAN","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041212945","display_name":"JAMES D. WAKEFIELD","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JAMES D. WAKEFIELD","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108393555","display_name":"Phebe J. Wilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"PHEBE J. WILSON","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084556157","display_name":"Daniel P. Zimmer","orcid":"https://orcid.org/0000-0002-2829-6398","observed_orcids":["https://orcid.org/0000-0002-2829-6398"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DANIEL P. ZIMMER","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049420240","display_name":"Marina Mihova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARINA MIHOVA","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089739039","display_name":"Jennifer G. Chickering","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JENNIFER CHICKERING","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111971530","display_name":"Dennis A. Ruff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DENNIS RUFF","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"MICHAEL L. HALL","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MICHAEL L. HALL","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111525044","display_name":"Mark G. Currie","orcid":"https://orcid.org/0009-0007-2239-5014","observed_orcids":["https://orcid.org/0009-0007-2239-5014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARK CURRIE","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110385743","display_name":"G. Todd Milne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. TODD MILNE","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109975511","display_name":"Albert T. Profy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ALBERT T. PROFY","raw_affiliation_strings":["Cambridge, MA, Raleigh, NC, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cambridge, MA, Raleigh, NC, San Antonio, TX","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3774,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.62119972,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"67","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.8535000085830688,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.8535000085830688,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.07090000063180923,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.02250000089406967,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soluble-guanylate-cyclase-stimulator","display_name":"soluble guanylate cyclase stimulator","score":0.9900000095367432},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9549999833106995},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nitric-oxide-signaling","display_name":"nitric oxide signaling","score":0.8899999856948853},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6679999828338623},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8090000152587891},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8669999837875366},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8309999704360962},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9200000166893005},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7319999933242798},{"id":"https://openalex.org/keywords/reactive-hyperemia-index","display_name":"reactive hyperemia index","score":0.8429999947547913},{"id":"https://openalex.org/keywords/platelet-function","display_name":"platelet function","score":0.9810000061988831},{"id":"https://openalex.org/keywords/microvascular-complications","display_name":"microvascular complications","score":0.621999979019165},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5419999957084656},{"id":"https://openalex.org/keywords/ambulatory-blood-pressure","display_name":"ambulatory blood pressure","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8904725313186646},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6166682839393616},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6084681749343872},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5642745494842529},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.535705029964447},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5263460874557495},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.44670072197914124},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.44416189193725586},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4236978590488434},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3941107988357544},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38703107833862305},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35124480724334717}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db18-1207-p","doi":"https://doi.org/10.2337/db18-1207-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-1207-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2808984911","https://openalex.org/W2995764953","https://openalex.org/W3035243246","https://openalex.org/W3112831521","https://openalex.org/W4396996981","https://openalex.org/W3035405356","https://openalex.org/W1870985972","https://openalex.org/W2145589944","https://openalex.org/W2107998222","https://openalex.org/W2073858857"],"abstract_inverted_index":{"Background:":[0],"Impaired":[1],"nitric":[2],"oxide":[3],"(NO)":[4],"signaling":[5],"through":[6,103],"soluble":[7],"guanylate":[8],"cyclase":[9],"(sGC)":[10],"has":[11],"been":[12],"associated":[13],"with":[14,82,260,289],"microvascular":[15],"complications":[16],"of":[17,38,51,76,167,220,282],"diabetes.":[18],"Praliciguat":[19,248],"(IW-1973),":[20],"an":[21,35],"sGC":[22],"stimulator":[23],"that":[24],"enhances":[25],"NO":[26],"signaling,":[27],"reduced":[28],"fasting":[29,225],"plasma":[30],"glucose":[31,227],"and":[32,56,74,88,93,110,124,129,174,241,269],"proteinuria":[33],"in":[34,47,79,151,267,272,284],"animal":[36],"model":[37],"diabetic":[39],"nephropathy.":[40],"In":[41],"a":[42,164],"Phase":[43,63],"1":[44],"clinical":[45],"study":[46,67],"healthy":[48],"adults,":[49],"doses":[50],"15-40":[52],"mg":[53,112],"were":[54,144,222],"tolerated":[55],"lowered":[57],"blood":[58,120],"pressure":[59],"(BP).":[60],"Methods:":[61],"This":[62],"2a":[64],"open-label":[65],"in-clinic":[66,275],"assessed":[68],"the":[69,218],"safety,":[70],"tolerability,":[71],"pharmacokinetics":[72],"(PK)":[73],"pharmacodynamics":[75],"oral":[77],"praliciguat":[78,113,198,283],"11":[80],"patients":[81,153,259,286],"type":[83],"2":[84,152,188],"diabetes":[85],"mellitus":[86],"(T2DM)":[87],"hypertension":[89,261],"on":[90,252,262],"stable":[91],"glycemic":[92],"BP":[94,123,159,185],"therapy.":[95],"Patients":[96],"received":[97],"sequential":[98],"3-day":[99],"dosing":[100],"cycles":[101],"escalating":[102,136],"placebo":[104],"(PBO),":[105],"10,":[106],"20,":[107],"30,":[108],"40":[109],"50":[111],"QD.":[114],"Assessments":[115],"included":[116],"adverse":[117],"events":[118],"(AEs),":[119],"chemistry,":[121],"ambulatory":[122],"heart":[125,202],"rate,":[126],"platelet":[127,255],"function,":[128],"reactive":[130],"hyperemia":[131],"index":[132],"(RHI).":[133],"Results:":[134],"The":[135],"dose":[137,199],"regimen":[138],"was":[139,154],"generally":[140],"well":[141],"tolerated;":[142],"there":[143],"no":[145,250],"serious":[146],"or":[147,254],"severe":[148],"AEs.":[149],"Escalation":[150],"stopped":[155],"due":[156],"to":[157,171,189,193,206],"asymptomatic":[158],"lowering.":[160],"Overall":[161],"PK":[162],"showed":[163,265],"median":[165],"Tmax":[166],"1-3":[168],"h,":[169],"low":[170],"moderate":[172],"variability,":[173],"\u223c2-fold":[175],"accumulation":[176],"supporting":[177],"QD":[178],"dosing.":[179],"Average":[180],"12-h":[181],"daytime":[182],"mean":[183],"arterial":[184],"decreased":[186],"by":[187],"9":[190],"mmHg":[191],"relative":[192],"time-matched":[194],"PBO":[195,212],"baseline":[196,213],"across":[197],"levels,":[200],"while":[201],"rate":[203],"increased":[204],"4":[205],"7":[207],"bpm.":[208],"Notable":[209],"changes":[210],"from":[211],"[mean":[214],"(95%":[215],"CI)]":[216],"at":[217],"end":[219],"treatment":[221],"seen":[223],"for":[224],"serum":[226],"[-26.5":[228],"mg/dL":[229,238],"(-43.4,":[230],"-9.5],":[231],"HbA1c":[232],"[-0.4%":[233],"(-0.8,":[234],"-0.04)],":[235],"cholesterol":[236],"[-43":[237],"(-67,":[239],"-20)],":[240],"body":[242],"weight":[243],"[-3.5":[244],"kg":[245],"(-4.9,":[246],"-2.0)].":[247],"had":[249],"effect":[251],"RHI":[253],"function.":[256],"Conclusion:":[257],"T2DM":[258,285],"standard":[263],"therapy":[264],"improvements":[266],"hemodynamics":[268],"metabolic":[270],"parameters":[271],"this":[273],"small":[274],"study.":[276],"These":[277],"results":[278],"support":[279],"further":[280],"evaluation":[281],"including":[287],"those":[288],"complications.":[290],"Disclosure":[291],"J.P.":[292],"Hanrahan:":[293],"Employee;":[294,299,314,335,347,354,364],"Self;":[295,300,305,315,320,336,341,348,355,360,376],"Ironwood.":[296],"J.D.":[297],"Wakefield:":[298],"Ironwood":[301,306,316,321,337,342,349,356,361,377],"Pharmaceuticals,":[302,307,317,322,338,343,350,357,362],"Inc..":[303,308,318,323,339,358,363],"Stock/Shareholder;":[304,319,340,359,368],"P.J.":[309],"Wilson:":[310],"None.":[311,326,329,332],"D.P.":[312],"Zimmer:":[313],"M.":[324,345],"Mihova:":[325],"J.":[327],"Chickering:":[328],"D.":[330],"Ruff:":[331],"M.L.":[333],"Hall:":[334],"Inc.":[344,351],"Currie:":[346],"G.":[352],"Milne:":[353],"Spouse/Partner;":[365,369],"Catabasis":[366,370],"Pharmaceuticals.":[367,371,378],"A.T.":[372],"Profy:":[373],"Other":[374],"Relationship;":[375]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2018-06-29T00:00:00"}